ID

38105

Description

A Study of Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Patients With Locally Recurrent or Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01740336

Link

https://clinicaltrials.gov/show/NCT01740336

Keywords

Versions (1)
  1. 9/17/19 9/17/19 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

September 17, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Breast Cancer NCT01740336

English

Eligibility Breast Cancer NCT01740336

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
female adult patients
Description

Gender | Adult

Data type

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0001675
histologically or cytologically confirmed adenocarcinoma of the breast, with measurable or non-measurable locally recurrent or metastatic disease
Description

Breast adenocarcinoma | Recurrent disease Locally Measurable | Neoplasm Metastasis Measurable | Recurrent disease Locally | Neoplasm Metastasis

Data type

boolean

Alias
UMLS CUI [1]
C0858252
UMLS CUI [2,1]
C0277556
UMLS CUI [2,2]
C1517927
UMLS CUI [2,3]
C1513040
UMLS CUI [3,1]
C0027627
UMLS CUI [3,2]
C1513040
UMLS CUI [4,1]
C0277556
UMLS CUI [4,2]
C1517927
UMLS CUI [5]
C0027627
human epidermal growth factor receptor 2 (her2)-negative and hr (estrogen receptor and/or progesterone receptor)-positive disease as defined by local guidelines
Description

Disease HER2 Negative | Disease Hormone Receptor Positive | Disease Estrogen receptor positive | Disease Progesterone receptor positive

Data type

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C2348908
UMLS CUI [2,1]
C0012634
UMLS CUI [2,2]
C0019929
UMLS CUI [2,3]
C1514241
UMLS CUI [3,1]
C0012634
UMLS CUI [3,2]
C0279754
UMLS CUI [4,1]
C0012634
UMLS CUI [4,2]
C0279759
eastern cooperative oncology group (ecog) performance status 0 or 1
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
adequate hematologic and end organ function
Description

Hematologic function | Organ function

Data type

boolean

Alias
UMLS CUI [1]
C0221130
UMLS CUI [2]
C0678852
women of childbearing potential must agree to remain abstinent or to use two adequate methods of contraception, including at least one method with a failure rate of < 1% per year, during the treatment period and for at least 30 days after the last dose of study treatment or 6 months after discontinuation of paclitaxel, whichever is longer
Description

Childbearing Potential Sexual Abstinence | Childbearing Potential Contraceptive methods Quantity

Data type

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0036899
UMLS CUI [2,1]
C3831118
UMLS CUI [2,2]
C0700589
UMLS CUI [2,3]
C1265611
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior non-capecitabine chemotherapy for locally recurrent or metastatic disease
Description

Prior Chemotherapy Recurrent disease Locally | Prior Chemotherapy Neoplasm Metastasis | Exception Capecitabine

Data type

boolean

Alias
UMLS CUI [1,1]
C1514457
UMLS CUI [1,2]
C0277556
UMLS CUI [1,3]
C1517927
UMLS CUI [2,1]
C1514457
UMLS CUI [2,2]
C0027627
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0671970
prior treatment with a pi3k inhibitor for advanced or metastatic breast cancer
Description

Prior Therapy Advanced breast cancer | Prior Therapy Secondary malignant neoplasm of female breast | PI3K Inhibitor

Data type

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C3495917
UMLS CUI [2,1]
C1514463
UMLS CUI [2,2]
C0346993
UMLS CUI [3]
C1519050
history of intolerance to a taxane-containing therapy
Description

Intolerance to Therapy Containing Taxane

Data type

boolean

Alias
UMLS CUI [1,1]
C1744706
UMLS CUI [1,2]
C0087111
UMLS CUI [1,3]
C0332256
UMLS CUI [1,4]
C0215136
history of clinically significant cardiac or pulmonary dysfunction
Description

Cardiac dysfunction | Pulmonary Dysfunction

Data type

boolean

Alias
UMLS CUI [1]
C3277906
UMLS CUI [2]
C1709770
history of malabsorption syndrome or other condition that would interfere with enteral absorption
Description

Malabsorption Syndrome | Condition Interferes with Absorption Enteral

Data type

boolean

Alias
UMLS CUI [1]
C0024523
UMLS CUI [2,1]
C0348080
UMLS CUI [2,2]
C0521102
UMLS CUI [2,3]
C0237442
UMLS CUI [2,4]
C1304890
clinically significant history of liver disease
Description

Liver disease

Data type

boolean

Alias
UMLS CUI [1]
C0023895
active autoimmune disease or active inflammatory disease
Description

Autoimmune Disease | Inflammatory disorder

Data type

boolean

Alias
UMLS CUI [1]
C0004364
UMLS CUI [2]
C1290884
immunocompromised status
Description

Immunocompromised patient

Data type

boolean

Alias
UMLS CUI [1]
C0085393
need for current chronic corticosteroid therapy
Description

Patient need for Steroid therapy chronic

Data type

boolean

Alias
UMLS CUI [1,1]
C0686904
UMLS CUI [1,2]
C0149783
UMLS CUI [1,3]
C0205191
pregnancy, lactation, or breastfeeding
Description

Pregnancy | Lactation | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0022925
UMLS CUI [3]
C0006147
current severe, uncontrolled systemic disease
Description

Systemic disease Severe Uncontrolled

Data type

boolean

Alias
UMLS CUI [1,1]
C0442893
UMLS CUI [1,2]
C0205082
UMLS CUI [1,3]
C0205318
known untreated or active central nervous system (cns) metastases
Description

CNS metastases Untreated | CNS metastases

Data type

boolean

Alias
UMLS CUI [1,1]
C0686377
UMLS CUI [1,2]
C0332155
UMLS CUI [2]
C0686377
Back to the top of the page

Similar models

Eligibility Breast Cancer NCT01740336

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Gender | Adult
Item
female adult patients
boolean
C0079399 (UMLS CUI [1])
C0001675 (UMLS CUI [2])
Breast adenocarcinoma | Recurrent disease Locally Measurable | Neoplasm Metastasis Measurable | Recurrent disease Locally | Neoplasm Metastasis
Item
histologically or cytologically confirmed adenocarcinoma of the breast, with measurable or non-measurable locally recurrent or metastatic disease
boolean
C0858252 (UMLS CUI [1])
C0277556 (UMLS CUI [2,1])
C1517927 (UMLS CUI [2,2])
C1513040 (UMLS CUI [2,3])
C0027627 (UMLS CUI [3,1])
C1513040 (UMLS CUI [3,2])
C0277556 (UMLS CUI [4,1])
C1517927 (UMLS CUI [4,2])
C0027627 (UMLS CUI [5])
Disease HER2 Negative | Disease Hormone Receptor Positive | Disease Estrogen receptor positive | Disease Progesterone receptor positive
Item
human epidermal growth factor receptor 2 (her2)-negative and hr (estrogen receptor and/or progesterone receptor)-positive disease as defined by local guidelines
boolean
C0012634 (UMLS CUI [1,1])
C2348908 (UMLS CUI [1,2])
C0012634 (UMLS CUI [2,1])
C0019929 (UMLS CUI [2,2])
C1514241 (UMLS CUI [2,3])
C0012634 (UMLS CUI [3,1])
C0279754 (UMLS CUI [3,2])
C0012634 (UMLS CUI [4,1])
C0279759 (UMLS CUI [4,2])
ECOG performance status
Item
eastern cooperative oncology group (ecog) performance status 0 or 1
boolean
C1520224 (UMLS CUI [1])
Hematologic function | Organ function
Item
adequate hematologic and end organ function
boolean
C0221130 (UMLS CUI [1])
C0678852 (UMLS CUI [2])
Childbearing Potential Sexual Abstinence | Childbearing Potential Contraceptive methods Quantity
Item
women of childbearing potential must agree to remain abstinent or to use two adequate methods of contraception, including at least one method with a failure rate of < 1% per year, during the treatment period and for at least 30 days after the last dose of study treatment or 6 months after discontinuation of paclitaxel, whichever is longer
boolean
C3831118 (UMLS CUI [1,1])
C0036899 (UMLS CUI [1,2])
C3831118 (UMLS CUI [2,1])
C0700589 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
Item Group
C0680251 (UMLS CUI)
Prior Chemotherapy Recurrent disease Locally | Prior Chemotherapy Neoplasm Metastasis | Exception Capecitabine
Item
prior non-capecitabine chemotherapy for locally recurrent or metastatic disease
boolean
C1514457 (UMLS CUI [1,1])
C0277556 (UMLS CUI [1,2])
C1517927 (UMLS CUI [1,3])
C1514457 (UMLS CUI [2,1])
C0027627 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0671970 (UMLS CUI [3,2])
Prior Therapy Advanced breast cancer | Prior Therapy Secondary malignant neoplasm of female breast | PI3K Inhibitor
Item
prior treatment with a pi3k inhibitor for advanced or metastatic breast cancer
boolean
C1514463 (UMLS CUI [1,1])
C3495917 (UMLS CUI [1,2])
C1514463 (UMLS CUI [2,1])
C0346993 (UMLS CUI [2,2])
C1519050 (UMLS CUI [3])
Intolerance to Therapy Containing Taxane
Item
history of intolerance to a taxane-containing therapy
boolean
C1744706 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0332256 (UMLS CUI [1,3])
C0215136 (UMLS CUI [1,4])
Cardiac dysfunction | Pulmonary Dysfunction
Item
history of clinically significant cardiac or pulmonary dysfunction
boolean
C3277906 (UMLS CUI [1])
C1709770 (UMLS CUI [2])
Malabsorption Syndrome | Condition Interferes with Absorption Enteral
Item
history of malabsorption syndrome or other condition that would interfere with enteral absorption
boolean
C0024523 (UMLS CUI [1])
C0348080 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C0237442 (UMLS CUI [2,3])
C1304890 (UMLS CUI [2,4])
Liver disease
Item
clinically significant history of liver disease
boolean
C0023895 (UMLS CUI [1])
Autoimmune Disease | Inflammatory disorder
Item
active autoimmune disease or active inflammatory disease
boolean
C0004364 (UMLS CUI [1])
C1290884 (UMLS CUI [2])
Immunocompromised patient
Item
immunocompromised status
boolean
C0085393 (UMLS CUI [1])
Patient need for Steroid therapy chronic
Item
need for current chronic corticosteroid therapy
boolean
C0686904 (UMLS CUI [1,1])
C0149783 (UMLS CUI [1,2])
C0205191 (UMLS CUI [1,3])
Pregnancy | Lactation | Breast Feeding
Item
pregnancy, lactation, or breastfeeding
boolean
C0032961 (UMLS CUI [1])
C0022925 (UMLS CUI [2])
C0006147 (UMLS CUI [3])
Systemic disease Severe Uncontrolled
Item
current severe, uncontrolled systemic disease
boolean
C0442893 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0205318 (UMLS CUI [1,3])
CNS metastases Untreated | CNS metastases
Item
known untreated or active central nervous system (cns) metastases
boolean
C0686377 (UMLS CUI [1,1])
C0332155 (UMLS CUI [1,2])
C0686377 (UMLS CUI [2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial